Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Plos One|July 13, 2026
Mapping global inequities in telemedicine implementation: An umbrella review of barriers and facilitatorsAngelo Capodici, Alessandro Filippeschi, Francesca Noci, et al.Dermatology Practical & Conceptual|November 14, 2025
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective StudyAntonella Di Cesare, Elia Rosi, Emanuele Trovato, et al.The Journal of Dermatological Treatment|January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.Dermatology and Therapy|June 9, 2026
Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective StudyLuciano Ibba, Sara Di Giulio, Piergiorgio Malagoli, et al.The Journal of Dermatological Treatment|September 24, 2025
Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity IndexNicoletta Bernardini, Annunziata Dattola, Giuseppe Paolo Antonio Gemma, et al.Dermatology and Therapy|July 3, 2025
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.International Journal of Dermatology|July 17, 2026
A Real-Life, Multicenter, Retrospective Study on Epidemiological and Clinical Features of Patients With Hidradenitis Suppurativa and Concomitant Down SyndromeChiara Moltrasio, Luisa Sarno, Giovanni Genovese, et al.Clinical and Experimental Dermatology|November 1, 2025
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis)Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, et al.Medicina (Kaunas, Lithuania)|February 26, 2025
High-Frequency and Ultra-High-Frequency Ultrasound in Dermatologic Diseases and Aesthetic MedicineGiulio Argalia, Alfonso Reginelli, Elisa Molinelli, et al.Dermatology and Therapy|April 23, 2025
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.Pageof 4